Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-27

FDA Approved: PYRAZINAMIDE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a generic version of pyrazinamide under an original application filed by Macleods Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyrazinamide (pyrazinamide)

Snippet

ORIG AP for PYRAZINAMIDE (PYRAZINAMIDE)